Planting the seed of doubts again, huh? That offering is history. We are anticipating better things to come from here on. Even AF can’t put a negative spin on this stock since trial is double blinded with the design a carbon copy of the p2 that passed with flying colors and with healthier patients than the last one.
News 
Market Data 
Discover 
